BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rayens E, Norris KA. Prevalence and Healthcare Burden of Fungal Infections in the United States, 2018. Open Forum Infect Dis 2022;9:ofab593. [PMID: 35036461 DOI: 10.1093/ofid/ofab593] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Eita AS, M. A. Makky A, Anter A, Khalil IA. Repurposing of atorvastatin emulsomes as a topical antifungal agent. Drug Delivery 2022;29:3414-3431. [DOI: 10.1080/10717544.2022.2149898] [Reference Citation Analysis]
2 Hammoudi Halat D, Younes S, Mourad N, Rahal M. Allylamines, Benzylamines, and Fungal Cell Permeability: A Review of Mechanistic Effects and Usefulness against Fungal Pathogens. Membranes 2022;12:1171. [DOI: 10.3390/membranes12121171] [Reference Citation Analysis]
3 Eita AS, Makky AM, Anter A, Khalil IA. Atorvastatin-loaded emulsomes foam as a topical antifungal formulation. International Journal of Pharmaceutics: X 2022. [DOI: 10.1016/j.ijpx.2022.100140] [Reference Citation Analysis]
4 Rayens E, Rayens MK, Norris KA. Demographic and Socioeconomic Factors Associated with Fungal Infection Risk, United States, 2019. Emerg Infect Dis 2022;28. [PMID: 36149028 DOI: 10.3201/eid2810.220391] [Reference Citation Analysis]
5 Patra S, Raney M, Pareek A, Kaur R. Epigenetic Regulation of Antifungal Drug Resistance. J Fungi (Basel) 2022;8:875. [PMID: 36012862 DOI: 10.3390/jof8080875] [Reference Citation Analysis]
6 Enache A, Cojocaru C, Samoila P, Bele A, Bostanaru A, Mares M, Harabagiu V. Evaluation of Physically and/or Chemically Modified Chitosan Hydrogels for Proficient Release of Insoluble Nystatin in Simulated Fluids. Gels 2022;8:495. [DOI: 10.3390/gels8080495] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Slarve M, Holznecht N, Reza H, Gilkes A, Slarve I, Olson J, Ernst W, Ho SO, Adler-Moore J, Fujii G. Recombinant Aspergillus fumigatus antigens Asp f 3 and Asp f 9 in liposomal vaccine protect mice against invasive pulmonary aspergillosis. Vaccine 2022;40:4160-8. [PMID: 35680499 DOI: 10.1016/j.vaccine.2022.05.057] [Reference Citation Analysis]
8 Shi C, Ye J, Xie Y, Dong R, Jin W, Wang L, Fang Y, Shan Q, Lin N. Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China. Front Public Health 2022;10:884846. [PMID: 35655452 DOI: 10.3389/fpubh.2022.884846] [Reference Citation Analysis]
9 Benedict K, Whitham HK, Jackson BR. Economic Burden of Fungal Diseases in the United States. Open Forum Infectious Diseases 2022;9:ofac097. [DOI: 10.1093/ofid/ofac097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]